IBD Research Resource Center

Trial Details

Not Recruiting

Basic Information

Clinical ID	c3266
Identifier	EUCTR2009-018085-35-DK
Trial Title	Intestinal Inflammation in Ankylosing Spondylitis assessed by Fecal Calprotectin, Capsular Endoscopy and Colonoscopy and the effects of Adalimumab on mucosal healing - INTASAH
Trial URL	Visit Original Page

Study Information

Study Results	No results available
Conditions	Ankylosing spondylitis __Inflammatory bowel disease MedDRA version: 14.0_Level: PT_Classification code 10061371_Term: Spondylitis_System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders_ MedDRA version: 14.0_Level: LLT_Classification code 10041672_Term: Spondylitis ankylosing_System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders_ MedDRA version: 14.0_Level: LLT_Classification code 10048398_Term: Spondylitis ankylosing aggravated_System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders_ MedDRA version: 14.0_Level: LLT_Classification code 10041671_Term: Spondylitis ankylopoietica_System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders_ MedDRA version: 14.0_Level: PT_Classification code 10002556_Term: Ankylosing spondylitis_System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders_ MedDRA version: 14.0_Level: LLT_Classification code 10041673_Term: Spondylitis NOS_System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Interventions	Trade Name: Humira Pharmaceutical Form: Solution for injection INN or Proposed INN: ADALIMUMAB CAS Number: 331731-18-1 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 40-

Participant Information

Sponsor	Regionalhospital Silkeborg
City	-
Country/Region	Denmark

Enrollment Criteria

Sex Requirement	NOT SPECIFIED
Age Requirement	-

Study Design

Study Type	Interventional clinical trial of medicinal product
Phase	PHASE4

Time Information

Start Date	2025-04-24
Primary Completion Date	-
Completion Date	-